Clinical Trial

Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy

Study acronym: (BLOOM)
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to see if lactulose can improve the effectiveness of immunotherapy in patients with advanced cancer.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-17
Trial Details
NCT Number NCT07354100
Lead Sponsor University of Chicago
Conditions Cancer
Enrollment 55 participants
Start Date 2026-12-15
Primary Completion 2029-04-13 (estimated)
Study Completion 2029-04-13 (estimated)
Updated on ClinicalTrials.gov 2026-06-16